We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

167 hedge funds and large institutions have $708M invested in Spectrum Pharmaceuticals Inc in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 37 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 37

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

1% more funds holding

Funds holding: 165167 (+2)

3% less capital invested

Capital invested by funds: $733M → $708M (-$25.3M)

73% less call options, than puts

Call options by funds: $3.81M | Put options by funds: $14M

Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
3.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
73
Reduced
37
Closed
19
Calls
$3.81M
Puts
$14M
Net Calls
-$10.1M
Net Calls Change
+$3.1M
Name Holding Trade Value Shares
Change
Change in
Stake
HF
126
HRT Financial
New York
$88K +$86.1K +10,643 New
SCM
127
Shelton Capital Management
Colorado
$87K
LTFS
128
Ladenburg Thalmann Financial Services
Florida
$86K -$1.69K -209 -2%
HSBC Holdings
129
HSBC Holdings
United Kingdom
$86K +$84.2K +10,413 New
MWM
130
Mission Wealth Management
California
$83K
NFC
131
Northeast Financial Consultants
Connecticut
$83K
AIP
132
Ameritas Investment Partners
Nebraska
$79K
LIA
133
LS Investment Advisors
Michigan
$57K
FMT
134
First Mercantile Trust
Tennessee
$51K +$9.34K +1,154 +23%
Zurich Cantonal Bank
135
Zurich Cantonal Bank
Switzerland
$44K
PMFA
136
Plante Moran Financial Advisors
Michigan
$35K
MOACM
137
Mutual of America Capital Management
New York
$34K +$2.64K +326 +9%
FWM
138
Focused Wealth Management
New York
$33K
TRCT
139
Tower Research Capital (TRC)
New York
$24K +$1.46K +180 +7%
SWA
140
Sutton Wealth Advisors
Florida
$22.3K
PA
141
Parallel Advisors
California
$19K -$971 -120 -5%
Royal Bank of Canada
142
Royal Bank of Canada
Ontario, Canada
$19K -$154 -19 -0.8%
Simplex Trading
143
Simplex Trading
Illinois
$15K -$94.7K -11,712 -86%
ONST
144
Old North State Trust
North Carolina
$11K
LFG
145
Larson Financial Group
Missouri
$9K +$8.49K +1,050 New
AG
146
Advisor Group
Arizona
$8K +$8.09K +1,000 +7,692%
Daiwa Securities Group
147
Daiwa Securities Group
Japan
$6K
PHK
148
Point72 Hong Kong
Hong Kong
$6K +$6.31K +780 New
FHA
149
Flagship Harbor Advisors
Massachusetts
$5K
Federated Hermes
150
Federated Hermes
Pennsylvania
$5K +$396 +49 +8%

SPPI Hedge Fund Activity: Q3 2019 in Review

167 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2019, worth a combined $708M — down 3.4% from $733M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SPPI positions and 19 closed out — a net gain of 2 holders — while 73 added to existing stakes and 37 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $6.94M. The largest seller was Citadel Advisors, cutting an estimated $6.43M.

  • 167 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2019, up from 165 in Q2 2019.
  • Funds reported $708M of Spectrum Pharmaceuticals Inc stock for Q3 2019, down 3.4% quarter-over-quarter.
  • 21 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2019 and 19 closed out, a net change of +2 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2019 was ArrowMark Colorado Holdings, an estimated $6.94M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2019 was Citadel Advisors, an estimated $6.43M sold.

Based on aggregated 13F filings for Q3 2019.